The conversation delves into the complexities of understanding infection rates, emphasizing the need for extensive testing to uncover the true number of mild cases. Insights suggest that while current estimates place the death rate around 1%, it could potentially be lower, though still significant. The speaker expresses skepticism about the likelihood of the rate dropping below 0.3% to 0.5%, hinting at a more severe outcome than seasonal flu.
